Key facts
- This page summarizes Mitch C. Hill's Form 4 filing for Inari Medical, Inc..
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Sep 2024, 16:35.
Mitch C. Hill - 12 Sep 2024 Form 4 Insider Report for Inari Medical, Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 12 Sep 2024
- Net transaction value
- -$134,014
- SEC form
- 4
- Accepted by SEC
- 13 Sep 2024, 16:35:16 UTC
- Prior SEC filing
- 05 Sep 2024
- Next SEC filing
- 02 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shannon Trevino, attorney-in-fact for Mitch C. Hill
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mitch C. Hill filed Form 4 for Inari Medical, Inc. on 13 Sep 2024.
Change
- Previous filing in this sequence was filed on 05 Sep 2024.
- Current net transaction value: -$134,014.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NARI
transaction
Common Stock
Options Exercise
- Transaction value
- $1,371
- Shares
- +3,000
- Change %
- +1.7%
- Price
- $0.4570
- Shares after
- 182,600
- Date
- 12 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
NARI
transaction
Common Stock
Sale
- Transaction value
- $71,407
- Shares
- -1,609
- Change %
- -0.88%
- Price
- $44.38
- Shares after
- 180,991
- Date
- 12 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F2
NARI
transaction
Common Stock
Sale
- Transaction value
- $40,808
- Shares
- -891
- Change %
- -0.49%
- Price
- $45.80
- Shares after
- 180,100
- Date
- 12 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F3
NARI
transaction
Common Stock
Sale
- Transaction value
- $23,170
- Shares
- -500
- Change %
- -0.28%
- Price
- $46.34
- Shares after
- 179,600
- Date
- 12 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F4
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,600
- Date
- 12 Sep 2024
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NARI
transaction
Derivative
Stock Options (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,000
- Change %
- -4.9%
- Price
- $0.000000
- Shares after
- 58,477
- Date
- 12 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- $0.4570
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $44.13 to $44.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $45.24 to $46.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F4
This transaction was executed in multiple trades at prices ranging from $46.24 to $46.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F5
Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter.